arsenic has been researched along with oridonin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, W; Du, Y; Li, J; Lou, H; Sun, Z; Villeneuve, NF; Wang, XJ; Wong, PK; Zhang, DD | 1 |
| Chen, G; Chen, JX; Hua, ZC; Tang, B; Wang, K; Yang, BY | 1 |
2 other study(ies) available for arsenic and oridonin
| Article | Year |
|---|---|
Oridonin confers protection against arsenic-induced toxicity through activation of the Nrf2-mediated defensive response.
Topics: Arsenic; Cell Line, Tumor; Diterpenes, Kaurane; Humans; NF-E2-Related Factor 2; Ubiquitination | 2008 |
Synergistic antitumor activity of oridonin and arsenic trioxide on hepatocellular carcinoma cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Diterpenes, Kaurane; Drug Synergism; Female; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Neoplasm Transplantation; NF-kappa B; Oxides; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; X-Linked Inhibitor of Apoptosis Protein | 2012 |